World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
23652
World Ranking
16164
National Ranking
8133

Overview

Ronald A. Lubet is affiliated with the National Institutes of Health in the United States. Their research spans multiple interconnected fields, primarily in medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. The main focus of their work includes immunotherapy, cancer immunology, and molecular mechanisms related to cancer progression and treatment.

Their scholarly output includes studies published in journals such as Cancer Prevention Research, Cancer Research, Advanced Science, Frontiers in Immunology, and Communications Biology. Their frequent publication venues indicate a concentration on cancer prevention and treatment research.

Among their recent papers are:

  • Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer, 2022, Advanced Science
  • Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention, 2021, Frontiers in Immunology
  • Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA, 2021, Communications Biology
  • Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention, 2023, npj Precision Oncology
  • Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat, 2021, Cancer Prevention Research

Lubet's research is situated within several subfields such as immunology, oncology, pulmonary and respiratory medicine, molecular biology, and surgery. These subfields reflect a multidisciplinary approach to cancer and immune system-related diseases.

Their main topics of study cover:

  • Immunotherapy and Immune Responses
  • Immune cells in cancer
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Cancer Research and Treatments
  • Vaccines and immunoinformatics approaches
  • T-cell and B-cell Immunology

Frequent collaborators within their research network include Shizuko Sei, Robert H. Shoemaker, Yian Wang, Katie Palen, and Bryon D. Johnson, reflecting ongoing partnerships in producing research outputs primarily focused on cancer biology and immunotherapy.

Best Publications

  • Chemopreventive Effect of Curcumin, a Naturally Occurring Anti-Inflammatory Agent, during the Promotion/Progression Stages of Colon Cancer

    Toshihiko Kawamori;Ronald Lubet;Vernon E. Steele;Gary J. Kelloff

  • Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat.

    Ronald A. Lubet;Richard T. Mayer;John W. Cameron;Raymond W. Nims

  • The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.

    Russell F. Jacoby;Karen Seibert;Carolyn E. Cole;Gary Kelloff

  • Chemoprevention of Colon Cancer by Specific Cyclooxygenase-2 Inhibitor, Celecoxib, Administered during Different Stages of Carcinogenesis

    Bandaru S. Reddy;Yoshinobu Hirose;Ronald Lubet;Vernon Steele

  • Progress in Cancer chemoprevention : Development of diet-derived chemopreventive agents

    Gary J. Kelloff;James A. Crowell;Vernon E. Steele;Ronald A. Lubet

  • Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.

    Susan M. Fischer;Herng-Hsang Lo;Gary B. Gordon;Karen Seibert

  • Expression of CYP1A1 Gene in Patients With Lung Cancer: Evidence for Cigarette Smoke-Induced Gene Expression in Normal Lung Tissue and for Altered Gene Regulation in Primary Pulmonary Carcinomas

    Theodore L. McLemore;Steven Adelberg;Mark C. Liu;Noreen A. McMahon

  • Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam

    Russell F. Jacoby;David J. Marshall;Michael A. Newton;Kristian Novakovic

  • Lipoxygenase inhibitors as potential cancer chemopreventives.

    Vernon E. Steele;Cathy A. Holmes;Ernest T. Hawk;Levy Kopelovich

  • Celecoxib Inhibits N-Butyl-N-(4-hydroxybutyl)-nitrosamine-induced Urinary Bladder Cancers in Male B6D2F1 Mice and Female Fischer-344 Rats

    Clinton J. Grubbs;Ronald A. Lubet;Alane T. Koki;Kathleen M. Leahy

  • Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats.

    Michael A. Pereira;Clinton J. Grubbs;Leta H. Barnes;Hong Li

  • Chemopreventive Drug Development: Perspectives and Progress

    Gary J. Kelloff;Charles W. Boone;James A. Crowell;Vernon E. Steele

  • Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 AND 2B, respectively, in the rat and mouse

    Pratibha V. Nerurkar;Sang S. Park;Paul E. Thomas;Raymond W. Nims

  • Strategy and planning for chemopreventive drug development: Clinical development plans II

    Gary J. Kelloff;James A. Crowell;Ernest T. Hawk;Vernon E. Steele

  • Measurement of cytochrome P-450 dependent dealkylation of alkoxy-phenoxazones in hepatic S9s and hepatocyte homogenates: effects of dicumarol

    Ronald A. Lubet;Raymond W. Nims;Richard T. Mayer;John W. Cameron

  • Chemoprevention of colon carcinogenesis by dietary perillyl alcohol

    Bandaru S. Reddy;C-X. Wang;Hanan Samaha;Ronald Lubet

  • Enhancement of experimental colon cancer by genistein

    Chinthalapally V. Rao;Chung Xiou Wang;Barbara Simi;Ronald Lubet

  • Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program

    V. E. Steele;R. C. Moon;R. A. Lubet;C. J. Grubbs

  • Mechanistic considerations in chemopreventive drug development.

    Gary J. Kelloff;Charles W. Boone;Vernon E. Steele;Judith R. Fay

  • Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.

    Russell F. Jacoby;Carolyn E. Cole;Kendra Tutsch;Michael A. Newton

Frequent Co-Authors

Vernon E. Steele
Vernon E. Steele National Institutes of Health
Ming You
Ming You Medical College of Wisconsin
Gary J. Kelloff
Gary J. Kelloff National Institutes of Health
Ann M. Bode
Ann M. Bode University of Minnesota
Zigang Dong
Zigang Dong University of Minnesota
Jerrold M. Ward
Jerrold M. Ward National Institutes of Health
Chinthalapally V. Rao
Chinthalapally V. Rao University of Oklahoma Health Sciences Center
Feng Zhu
Feng Zhu Zhejiang University
Robert H. Shoemaker
Robert H. Shoemaker National Institutes of Health
Paul E. Thomas
Paul E. Thomas Rutgers, The State University of New Jersey

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up a variety of related online degrees and career pathways. Beyond the traditional MD route, healthcare administration is a growing field for those interested in the business and organizational side of hospitals and clinics. Earning a health care administration online degree can be a flexible, affordable entry point, preparing graduates for management roles in healthcare settings.

For those looking to advance their credentials even further, the most affordable mha programs offer focused training in leadership, policy, and strategic decision-making. Similarly, nurses seeking top-level roles can consider the cheapest dnp program, which opens doors to advanced clinical practice, administration, or teaching.

Another promising pathway is pharmacy, where accelerated and flexible options like a 3 year online pharmd program help meet the demand for skilled pharmacists. These alternative and supplementary degrees are great for students seeking impactful healthcare careers without attending medical school.

Best Scientists Citing Ronald A. Lubet

Trending Scientists

Recently Published Articles